Dates of event, diagnosis, and implant: dates estimated.Unique device identifier (udi#): in the absence of a reported part number, the udi cannot be calculated.The device was not returned for evaluation.The reported patient effects of myocardial infarction, cerebrovascular accident, and thrombosis, are listed in the xience v everolimus eluting coronary stent systems instructions for use as known patient effects of coronary stenting procedures.A review of the lot history record and complaint history could not be conducted because the part and lot numbers were not provided.A conclusive cause for the reported patient effects of myocardial infarction, cerebrovascular accident, hemorrhage and thrombosis, and the relationship to the product, if any, cannot be determined.However, the treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.The additional patient effects of death referenced is being filed under a separate medwatch report #.
|
It was reported through a research article identifying xience v drug-eluting stents that may be related to the following: death, myocardial infarction, stroke, thrombosis, minor/major bleeding, and target vessel revascularization.Details are listed in the article, titled ¿6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin.".
|